Cover Image
市場調查報告書

電子臨床實驗技術的全球市場

e-Clinical Trial Technologies

出版商 Global Industry Analysts, Inc. 商品編碼 248867
出版日期 內容資訊 英文 321 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
電子臨床實驗技術的全球市場 e-Clinical Trial Technologies
出版日期: 2018年01月01日 內容資訊: 英文 321 Pages
簡介

這份報告提供全球電子臨床實驗技術市場相關調查分析,提供您電子資料收集系統(EDC)解決方案,臨床實驗管理系統(CTMS),電子病歷報告結果(ePRO)系統,非人為化及臨床實驗支援管理(RTSM)等各市場區隔考察,以及美國,加拿大,歐洲,亞太地區,全球其他各國各市場相關資料分析,彙整2013年到2020年的市場預測,過去7年的市場分析,及主要企業簡介等相關資訊。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 產業概要
    • 簡介
    • 醫療費削減的影響
    • 市場預測
    • 市場從已開發國家轉移到開發中國家
    • 接收電子資料的法制化
    • 成本控制:電子臨床實驗引進增加的重要因素
    • 贊助商的重組帶來的競爭風險
    • 政府的法規要求變更為高價技術的風險
  • 市場動態
    • EDC市場區隔展現出上升趨勢
    • 平板電腦形式的資料收集設備是EDC市場上的趨勢
    • 有形成本:推動CTMS解決方案的迅速引進
    • 由於第四代臨床實驗的增加確立了臨床實驗管理系統所扮演的角色
    • 電子病歷報告結果(ePRO)解決方案急速取代以紙為基礎的PRO系統
    • 客制化/配置式臨床實驗藥供給管理(RTSM)
    • 自助服務RTSM系統取代傳統的IVR/IWR軟體
    • 單獨型電子臨床實驗系統的整合需求
    • 下一代電子臨床實驗系統
    • 開放原始碼
    • 行動技術
    • SaaS型解決方案的增加
  • 競爭情形
  • 產品簡介
    • 電子臨床實驗定義
    • 電子臨床實驗的優點
    • 法規的遵守
    • 臨床實驗概要
    • 電子臨床實驗所使用的系統
  • 產品/服務的簡介
  • 產品的銷售與核准
  • 主要企業
  • 全球市場概要

第3章 市場

  • 美國
  • 加拿大
  • 歐洲
  • 亞太地區
  • 全球其他各國

第4章 競爭情形

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-6744

This report analyzes the worldwide markets for e-Clinical Trial Technologies in US$ Million. The Global market for e-Clinical Trial Technologies in this report is analyzed by the following Segments: Electronic Data Capture (EDC) Solutions, Clinical Trial Management System (CTMS), Electronic Patient Reported Outcome (ePRO), and Randomization and Trial Supply Management (RTSM). The Global Electronic Data Capture (EDC) Market in this report is analyzed by the following Clinical Trial Phase: Phase I, Phase II, Phase III, and Phase IV. The Global Clinical Trial Management System (CTMS) Market in this report is analyzed by the following Product Type: Web-based CTMS, Cloud-based CTMS, and On-Premise CTMS. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 84 companies including many key and niche players such as -

Almac Group
ArisGlobal LLC
BioClinica
Clinipace Worldwide
Cmed Technology Ltd.
DATATRAK International, Inc.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations

Disclaimers

Data Interpretation & Reporting Level

  • Quantitative Techniques & Analytics

Product Definitions and Scope of Study

  • Product Segment Definitions
    • Electronic Data Capture (EDC) Solutions
    • Clinical Trial Management System (CTMS)
    • Electronic Patient Reported Outcome (ePRO)
    • Randomization and Trial Supply Management (RTSM)

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • A Prelude
    • Table 1: Increase in R&D Costs of a New Approved Drug: 1980s to 2010s
  • Cost-Containment: An Important Factor Increasing the Uptake of e-Clinical Trial Technologies
    • Table 2: Number of Companies with Active Pipelines: 2010 to 2017 (includes corresponding Graph/Chart)
    • Table 3: Top Ten Pharma Companies based on Number of Drugs in Pipeline: 2017 (includes corresponding Graph/Chart)
  • Global Market Overview
  • Increasing Investments in Clinical Research Drive the Global e-Clinical solutions Market
    • Table 4: Global Pharmaceutical R&D Spending (US$ Billion) for the Years 2010 through 2017 (includes corresponding Graph/Chart)
  • Clinical Trials Adopt Technologies for Various Phases
  • e-Clinical Trial Technologies Market by Delivery Mode
  • Major Players
  • Market Gravitates from Developed Countries to Developing Countries
    • Table 5: Distribution of Clinical Trials by Location: As of January 09, 2018 (includes corresponding Graph/Chart)
    • Table 6: Cost of Patient Visits in Select Countries (2016): A Comparison (includes corresponding Graph/Chart)
    • Table 7: Cost Per Patient Per Visit in Select Countries: 2016 (includes corresponding Graph/Chart)
  • Outsourcing of Clinical Studies to Developing Countries Benefits Market
  • Globalization Boosts e-Clinical Trials Market
    • Table 8: Total Number of Registered Clinical Studies: 2010-2017 (As of December 11, 2017) (includes corresponding Graph/Chart)
    • Table 9: Total Number of Registered Clinical Trials with Results posted Worldwide: 2010-2017 (As of December 11, 2017) (includes corresponding Graph/Chart)
    • Table 10: Total Number of Studies based on Region: 2017 (As of December 11, 2017) (includes corresponding Graph/Chart)
  • Key Challenges for e-Clinical Trials
  • Role of Contract Research Organizations (CROs) in Clinical Activity
  • Major CROs with Internally Developed CTMS Systems
  • CRO Acquisitions: Clinical Trial Technologies

2. SEGMENT ANALYSIS

  • Electronic Data Capture (EDC)
  • EDC Segment Witnesses Rapid Growth
    • Table 11: Increasing Clinical Trial Failure Rate: 1990 and 2010 (includes corresponding Graph/Chart)
    • Table 12: Estimated Share of Electronic Data Capture Usage for New Drug Trials (includes corresponding Graph/Chart)
    • EDC Platforms Utilized by Select CROs
  • Competition
    • Medidata Solutions Inc. - A Leading EDC Provider
      • Select Customers of Medidata's Rave
      • Select Customers of Oracle's EDC
  • Factors influencing EDC Selection
    • Vendors Track Record
    • Regulatory Compliance
    • Data Security Standards
  • Trend towards Third-Party EDC Systems Gains Momentum
  • EDCs Boost Use of Clinical Trials
    • EDC for Monitoring Patient Logistics
    • EDC and Direct Monitoring of Patients
    • EDC for Managing Medical Records
  • Clinical Trial Management Systems (CTMS) Market
  • Tangible Cost-Savings Bolster Rapid Uptake of CTMS Solutions
  • Web-based Systems Dominate, Cloud-Based to Witness Fastest Growth
    • Increased Demand for Cloud-based and Other Advanced CTMS
  • Key Players in the CTMS Market
    • Select Major Clinical Trial Management Systems (CTMS) Providers Worldwide
  • Impact of CTMS and other Services on Pharma Industry
  • Electronic Patient Record Outcome (ePRO)
  • Electronic Patient Record (ePRO) Solutions Replace Paper-Based PRO systems
    • Select ePRO Vendors
  • Major Technology Trends Expected to Revolutionize the ePro Market
    • Big Data
    • Wearable Health Trackers Becoming Mainstream
    • BYOD Strategy
    • Growing Usage of Tablets and Mobile
    • Real-time Feedback and Insights
    • Adopting Cloud and Multi-tenant SaaS
    • Consumerization of User Experience
  • ePatient-Reported Outcomes (PROs) Gain Importance in Oncology Studies
  • Randomization and Trial Supply Management (RTSM)
  • Preference Grows for Customized/Configured RTSM
  • Interactive Voice Response System (IVRS)
  • Multifarious Operational Benefits Drive IVRS Adoption
  • Globalization of Clinical Trials Throws Up Challenges for IVR/IWR System Developers

3. KEY GROWTH DRIVERS AND MARKET TRENDS

  • Surging Global Population Offers Increased Growth Opportunities
    • Table 13: Top 25 Countries Worldwide in Terms of Population: 2015 & 2016 (In Million) (includes corresponding Graph/Chart)
  • Pharmaceutical Firms and CROs to Drive Adoption Rate
  • Rise in Clinical Trial Complexities Propels e-Clinical Trial Technologies Demand
    • Table 14: Increasing Complexity of a Typical Phase 3 Clinical Trial: 2002 Vs. 2012
  • CROs - The Targeted Customers for e-Clinical Trial Technologies
    • Table 15: Leading CROs Worldwide by Revenue: 2016 (includes corresponding Graph/Chart)
  • Outsourcing of R&D Projects to Propel CRO Market, Driving Demand
    • Table 16: Global Biopharma % R&D Outsourcing (2014-2020) (includes corresponding Graph/Chart)
    • Noteworthy Contracts of Major CROs
  • CROs Adept with New Technologies to See More Business in Future
  • Increased Importance of e-Clinical Integration
  • Big Data and Patient Centricity: Areas to Increase Focus Upon
    • Table 17: Percentage of Companies Utilizing Advanced Technologies in Clinical Trials (includes corresponding Graph/Chart)
    • Table 18: Utilization of Advanced Technologies in Clinical Trials across North America and Europe (includes corresponding Graph/Chart)
  • Esource Documentation Witnesses Increased Traction
  • Increased Adoption of electronic Trial Master File (eTMFs)
  • Risk-Based Monitoring Witnesses New Modifications
  • Growing Implementation of e-Consent
  • Increased Investments in Virtual Clinical Trials
  • Open Source - Emerging Solutions in Clinical Trials Domain
  • Select Open Source Technologies for Clinical Trials by Application Area
  • Benefits over Proprietary Technologies to Encourage Adoption
  • EDC- The Most Attractive Application for Open Source
  • Conversion to CDISC - An Emerging Application for Open Source Solutions
  • Mobile Technologies to Help Trial Operators in Tackling Challenges
    • Table 19: Smartphone Penetration as a Proportion (%) of Total Mobile Users in Select Countries (2017) (includes corresponding Graph/Chart)
    • Table 20: World Smartphones Market by Region/ Country (2016): Percentage Breakdown of Annual Unit Shipments for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Middle East & Africa (includes corresponding Graph/Chart)
    • Table 21: 4G Network Availability (In %) in Select Countries (2016) (includes corresponding Graph/Chart)
    • Table 22: Average 4G Network Speeds (in Mbps) in Select Countries (2016) (includes corresponding Graph/Chart)
  • Smartphones & Tablets: The New Age ePRO Devices

4. PRODUCT PROFILE

  • Defining e-Clinical Trials
  • e-Clinical Solutions Enhance Clinical Trial Efficiency
  • Key Advantages offered by Integrated e-Clinical Solutions include:
  • Effective Deployment of an e-Clinical Solution
  • Enterprise-Level Benefits
  • Benefits Offered by e-Clinical Trials
  • Transparency
  • Dynamic Program Management
  • Effective Trial Drug Supply
  • Effective Study Randomization
  • Enhanced Collaboration
  • Dynamic Site Management
  • Less Frequent Investigational Site Visits
  • Faster Go No-Go Decisions
  • Better Planning
  • Regulatory Compliance
  • CDISC Standards
  • Clinical Trials - In a Nutshell
  • Summarization of Clinical Trial Phases & Time Line for Drug Development
  • Systems Used in e-Clinical Trials
  • Electronic Data Capture Solutions (EDC)
    • Benefits of EDC
    • EDC and Paper CRFs - A Comparison
    • Recent Advancements in EDC
  • Clinical Trial Management System (CTMS)
    • CDMS to CTMS: The Evolutionary Move to eDevelopment
    • CROs - The Targeted Customers for CTMS
    • Clinical Trial Image Management System (CTMS)
  • Electronic Patient Reported Outcome (ePRO)
  • Electronic Diaries
  • Randomization and Trial Supply Management (RTSM)
  • Interactive Voice Response Systems (IVRS)
    • Technologies Used in IVR
  • Interactive Web Response Systems (IWRS)

5. PRODUCT/SERVICE INTRODUCTIONS

  • ArisGlobal Introduces LifeSphere Clinical
  • Oracle Health Sciences Unveils Oracle Clinical One
  • MedNet Solutions Introduces iMedNet
  • Prelude Dynamics Introduces Two Solutions
  • PAREXEL Unveils Patient Sensor Solution
  • Prelude Dynamics Introduces VISION 9
  • Veeva Systems Unveils Veeva Vault EDC and eSource
  • Bioclinica Introduces Safety and Regulatory Software Products
  • DZS Clinical Services Unveils ClinPlus 3.1e-Clinical Software
  • Bioclinica Introduces OnPoint Direct
  • Bioclinica Demonstrates EDC System from EHR to CDASH CRFs
  • BioClinica Introduces e-Clinical CRO Partner Alliance Program
  • DATATRAK Introduces UX CTMS 360

6. RECENT INDUSTRY ACTIVITY

  • Novum Selects OmniComm's TrialMaster EDC
  • OmniComm Inks Contract with Beijing Hospital of the Ministry of Health
  • Montrium Partners with MAPS
  • MedNet Solutions Partners with arivis
  • OmniComm Systems Secures EU-U.S. Privacy Shield Certification
  • SRD Selects OmniComm's TrialMaster EDC Technology
  • AB Cube Joins Health App xChange
  • Anju Software Acquires ClinPlus
  • DATATRAK Partners with Sisense
  • Orbita Collaborates with ERT
  • MedNet Solutions Obtains Privacy Shield Certification
  • Medidata Acquires Mytrus
  • Medidata Partners with Karyopharm
  • OmniComm Collaborates with Bio-Optronics
  • OmniComm Systems Signs Agreement with MediStat
  • OmniComm Signs Landmark Contracts with Major Clinical Research Organizations
  • Almac Group Collaborates with Exostar
  • ERT Takes Over Exco InTouch
  • Almac Group Partners with inVentiv Health
  • OmniComm Provides EDC Services to a Major Research Hospital
  • Bracket Acquires CLINapps
  • e-ClinicalHealth Collaborates with Clinerion
  • Orbus Therapeutics Selects DSG to Provide Fully Supported eCaseLink EDC System
  • Cinven Acquires Bioclinica
  • Top 15 Pharma Company Selects TrialOne to Automate its Entire Phase I/BA & BE Clinic
  • Parallel 6 Joins Bioclinic's eHealth App xChange
  • Pfizer Selects Oracle's Clinical Trial Technologies
  • IMS Health Merges with Quintiles
  • OmniComm System Inks five-year, Multi-Million Dollar Agreement with CROMSOURCE
  • OmniComm Inks Agreement with Canadian Pharmaceutical Drug Developer
  • Bioclinica Provides RBM Solution for Clinical Trials
  • Bioclinica Takes Over Clinverse
  • Parallel 6 Acquires nPruv
  • Clinlogix Partners with MedNet Solutions
  • OmniComm Inks five year, Multi-Million Dollar Agreement with Major CRO
  • Global Biopharmaceutical Selects TrialMaster EDC for CNS Drug Trials
  • Integrium Inks Licensing Agreement for DSG's eCaseLink Solutions & Services
  • BioClinica Partners with Kinapse
  • ERT Acquires Boston-based PHT Corporation
  • Clinical Ink Mergers with CentrosHealth
  • PRA Health Sciences Acquires Value Health Solutions
  • OmniComm Systems Buys IRT Technology From Clinquest

7. FOCUS ON SELECT PLAYERS

  • Almac Group (UK)
  • ArisGlobal LLC (USA)
  • BioClinica (USA)
  • Clinipace Worldwide (USA)
  • Cmed Technology Ltd (UK)
  • DATATRAK International, Inc. (USA)
  • DSG Inc. (USA)
  • DZS Software Solutions, Inc. (USA)
  • eResearch Technology, Inc. (USA)
  • IBM Watson Health (USA)
  • Medidata Solutions, Inc. (USA)
  • MedNet Solutions (USA)
  • Nextrials Inc. (USA)
  • OmniComm Systems, Inc. (USA)
  • Oracle Corp. (USA)
  • PAREXEL International Corp. (USA)
  • PAREXEL Informatics Inc (USA)
  • Prelude Dynamics LLC (USA)
  • SAS Institute Inc. (USA)
  • Target Health Inc. (USA)

8. GLOBAL MARKET PERSPECTIVE

    • Table 23: World Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Geographic Region - US, Canada, Europe, Asia-Pacific (Including Japan), and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 24: World Historic Review for e-Clinical Trial Technologies by Geographic Region - US, Canada, Europe, Asia-Pacific (Including Japan), and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 25: World 14-Year Perspective for e-Clinical Trial Technologies by Geographic Region - Percentage Breakdown of Dollar Revenues for US, Canada, Europe, Asia-Pacific (Including Japan), and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 26: World Recent Past, Current & Future Analysis for e-Clinical Trial Technologies by Application - EDC, CTMS, ePROs, and RTSM Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 27: World Historic Review for e-Clinical Trial Technologies by Application - EDC, CTMS, ePROs, and RTSM Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 28: World 14-Year Perspective for e-Clinical Trial Technologies by Application - Percentage Breakdown of Dollar Revenues for EDC, CTMS, ePROs, and RTSM Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 29: World Recent Past, Current & Future Analysis for Electronic Data Capture (EDC) by Clinical Trial Phase - Phase I, II, III, and IV Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 30: World Historic Review for Electronic Data Capture (EDC) by Clinical Trial Phase - Phase I, II, III, and IV Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 31: World 14-Year Perspective for Electronic Data Capture (EDC) by Clinical Trial Phase - Percentage Breakdown of Dollar Revenues for Phase I, II, III, and IV Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 32: World Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery Mode - Web-based CTMS, Cloud-based CTMS and On-Premise CTMS Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 33: World Historic Review for Clinical Trial Management Systems (CTMS) by Delivery Mode - Web-based CTMS, Cloud-based CTMS and On-Premise CTMS Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 34: World 14-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery Mode - Percentage Breakdown of Dollar Revenues for Web-based CTMS, Cloud-based CTMS and On-Premise CTMS Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 35: World Recent Past, Current & Future Analysis for Electronic Patient Reported Outcomes (ePRO) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 36: World Historic Review for Electronic Patient Reported Outcomes (ePRO) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 37: World Recent Past, Current & Future Analysis for Randomization and Trial Supply Management (RTSM) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 38: World Historic Review for Randomization and Trial Supply Management (RTSM) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • United States: The Largest Market for e-Clinical Trial Technologies Worldwide
    • Table 39: The US Life Science R&D Spending (In US$ Billion): 2014- 2016 (includes corresponding Graph/Chart)
    • Table 40: Increased Funding for Clinical Trials and Supportive Activities in the US: 2013 to 2018 (includes corresponding Graph/Chart)
    • The US Leads the Pharma R&D Companies
    • Table 41: R&D Companies Distribution by Region: 2017 (includes corresponding Graph/Chart)
    • Drug Developers Rely on CROs to Improve Trial Efficiency and Cost Savings
    • Growing Demand from CROs Drives the CTMS Market
    • Increasing Adoption of Adaptive Clinical Trials
    • Risk-based Monitoring Catches Pace
    • Paradigm Shift in Oncology Clinical Trial
    • New FDA Standards
    • FDA Binding Guidance Comes into Effect
    • Product/Service Introductions
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 42: The US Recent Past, Current & Future Analysis for e-Clinical Trial Technologies Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 43: The US Historic Review for e-Clinical Trial Technologies Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 44: Canadian Recent Past, Current & Future Analysis for e-Clinical Trial Technologies Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 45: Canadian Historic Review for e-Clinical Trial Technologies Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

3. EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Clinical Trial Regulation to Strengthen EU's Position in Clinical Research
    • EMA Focuses on Enhancing Patient Safety in First-In-Human Clinical Trials
    • Brexit Referendum to Threaten UK's Position as Leading Hub for Clinical Trials
    • Strategic Corporate Development
    • Select Key Players
  • B. Market Analytics
    • Table 46: European Recent Past, Current & Future Analysis for e-Clinical Trial Technologies Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 47: European Historic Review for e-Clinical Trial Technologies Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

4. ASIA-PACIFIC

  • A. Market Analysis
    • Asia-Pacific: The Fastest Growing Region for e-Clinical Trial Technologies
    • Table 48: Total Number of Clinical Studies Conducted in Asia: 2017 (includes corresponding Graph/Chart)
    • R&D Outsourcing in Life Sciences on the Rise
    • An Overview of Key Markets
      • Japan
      • China
      • China Rapidly Emerges as a Compelling Destination for Clinical Trials
      • India
      • A Thriving Clinical Trials Market
      • Reasons for Outsourcing to India
      • Approval Process in India
      • Regulatory Issues
      • Improper Functioning of CROs
      • Clinical Study Liabilities
      • Access to Treatment Following Clinical Trial
      • Legislation to Monitor Drug Trials
      • Australia
      • Australia to Retain Position as Compelling Hub for Early-Phase Clinical Research
      • Initiatives Taken by Australian Government for Popularizing Clinical Trials
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 49: Asia-Pacific (including Japan) Recent Past, Current & Future Analysis for e-Clinical Trial Technologies Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 50: Asia-Pacific (including Japan) Historic Review for e-Clinical Trial Technologies Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

5. REST OF WORLD

  • A. Market Analysis
    • Current & Future Analysis
    • Latin America
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 51: Rest of World Recent Past, Current & Future Analysis for e-Clinical Trial Technologies Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 52: Rest of World Historic Review for e-Clinical Trial Technologies Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Back to Top